Peripheral nerve injury results in the activation of a number of transcription factors (TFs) in injured neurons, some of which may be key regulators of the regeneration-associated gene (RAG) programme. Among known RAG TFs, ATF3, Smad1, STAT3 and c-Jun have all been linked to successful axonal regeneration and have known functional and physical interactions. We hypothesised that TF expression would promote regeneration of the central axon branch of DRG neurons in the absence of a peripheral nerve lesion and that simultaneous overexpression of multiple RAG TFs would lead to greater effects than delivery of a single TF. Using adeno-associated viral vectors, we overexpressed either the combination of ATF3, Smad1, STAT3 and c-Jun with farnesylated GFP (fGFP), ATF3 only with fGFP, or fGFP only, in DRG neurons and assessed axonal regeneration after dorsal root transection or dorsal column injury and functional improvement after dorsal root injury. ATF3 alone and the combination of TFs promoted faster regeneration in the injured dorsal root. Surprisingly, however, the combination did not perform better than ATF3 alone. Neither treatment was able to induce functional improvement on sensory tests after dorsal root injury or promote regeneration in a dorsal column injury model. The lack of synergistic effects among these factors indicates that while they do increase the speed of axon growth, there may be functional redundancy between these TFs. Because axon growth is considerably less than that seen after a conditioning lesion, it appears these TFs do not induce the full regeneration programme.
Introduction
Therapeutic activation of the regeneration-associated gene (RAG) expression programme in injured central nervous system neurons would be highly desirable to promote repair after CNS injury. Induction of this programme in primary sensory neurons by a peripheral nerve injury leads to sprouting of sensory fibres in the injured spinal cord and across the dorsal root entry zone (DREZ) after dorsal root injury, unlike after central axotomy alone, indicating that a strong RAG response may be able to drive some regeneration in CNS environments (1) (2) (3) (4) (5) . It is not clear how the RAG programme is regulated although a large number of regeneration-associated transcription factors (TFs) are upregulated or activated post-translationally. Such TFs are likely to be key molecules that coordinate the expression of the RAG programme and so are candidate targets for intervention to activate the regeneration programme.
In this study, we focus on four TFs, which have been functionally linked to regeneration. ATF3, c-Jun and Smad1 are all upregulated in regenerating neurons, whereas STAT3 is activated by phosphorylation. Furthermore, experimental overexpression, activation or knockout of these factors in vivo and in vitro indicates that they partly regulate the regenerative response of neurons (6) (7) (8) (9) (10) (11) (12) (13) (14) . However, none of these factors alone is sufficient to drive long distance axonal regeneration (i.e. more than a few hundred microns) in the injured central nervous system.
We propose that co-expression of multiple RAG TFs would more strongly activate the neuronal regeneration programme. Transcription factors frequently act in concert to drive gene expression by forming transcriptional complexes or other co-operative mechanisms. Key TFs often co-operate to synergistically regulate target promoters and in many cases physically interact. The requirement for multiple TFs to regulate individual genes can involve several mechanisms including the assembly of multi-factor complexes (enhanceosomes), heterotypic and homotypic co-operative binding, allosteric effects and chromatin remodelling (15) (16) (17) .
In fact the combinatorial binding of TFs to promoters and the interactions between TFs are thought to be the mechanism by which the specificity of gene regulation is achieved (15) . The potential of delivery of multiple TFs to profoundly affect the cell state is made clear by the fact that fibroblasts can be reprogrammed into pluripotency with the co-delivery of four TFs (18) . For neuroregeneration, these observations imply that multiple TFs need to be expressed simultaneously to convert an injured neuron into the growth or regenerative state.
Several data indicate that c-Jun, ATF3, STAT3 and Smad1 may be a set of TFs that co-operates in transcriptional regulation of RAGs. Physical and functional interactions take place between these factors, with synergistic effects on function and promoter activity. ATF3 and c-Jun dimerize, and c-Jun enhanced ATF3-driven neurite growth in vitro (19, 20) . c-Jun and STAT3 directly interact (21) , and this leads to synergistic promoter activation (22, 23) . A complex of c-Jun, ATF3 and STAT3 co-operatively regulates a neuronal damage-induced promoter (24) . Smad family members interact with c-Jun in AP1 complexes to synergistically regulate c-Jun promoter activity (25) (26) (27) and Smad1 acts synergistically with STAT3 in a complex with CBP (28) .
Given these functional links between ATF3, c-Jun, STAT3 and Smad1, we hypothesized that co-expression of this combination of TFs might induce a robust regenerative response in DRG neurons. The aim of the present study therefore, is to establish, in principle, whether artificial activation of a strong regenerative response can be achieved by multiple TF delivery. The therapeutic intervention is given prior to the injury, in order that the viralvector-driven expression is well-established when the lesion is made. Although this is different to the clinical situation, by delivering the therapy or treatment before the lesion we are attempting to mimic the most successful form of the conditioning lesion paradigm, where the sciatic nerve lesion is most effective 1-2 weeks before spinal cord injury (5) . In addition, because overexpressing these TFs individually can have positive effects on regeneration, most clearly in the case of ATF3 (11) , to determine whether combined expression of TFs has benefits over expressing a single TF, we compared axon regeneration after delivery of the TF combination to that induced by ATF3 alone.
We used a dual promoter AAV vector (29) to co-express each TF (ATF3, c-Jun, STAT3 or Smad1) and GFP in rat DRG. Regeneration of the injured central axon branches of these neurons was examined after dorsal root and dorsal column injury, in the absence of a conditioning lesion.
Materials and Methods
Plasmids and viral vectors ATF3 (IMAGE clone 7100767), c-Jun (IMAGE clone 7124370) and the constitutively active phospho-mimetic Smad1 form Smad1-EVE (30) (22993; Addgene) were inserted into the dual promoter plasmid pAGLWFI (29) , which co-expresses the axonally transported farnesylated GFP (fGFP). The dominant active STAT3 mutant STAT3C (18) was inserted under the short CAG promoter between the ITRs of AAV2 followed by a WPRE and the BgH poly-adenylation signal. The fGFP-only vector was made using pAGLWFI with the second expression slot left empty. The production and titration of AAV serotype 5 vector particles was performed as described (29) .
Experimental animals and surgical procedures
In this study, Fisher 344 rats (180-250 g, Harlan, Horst, The Netherlands) were used. Animals were housed under standard conditions with food and water ad libitum, and a 12-h:12-h light/dark cycle. All experimental procedures and postoperative care were carried out with approval from the local animal experimentation ethical committee.
Dorsal root injury
Animals were divided into three treatment groups (combination, ATF3 and fGFP only) and three time points, 10 days, 20 days and 8 weeks after dorsal root transection and repair. Viral vectors were injected into the left L4 and L5 DRG as described (31) of six animals per group for the early time points and nine animals per group for the 8-week time point. The combination group received DRG injections containing a mixture of four vectors expressing ATF3, c-Jun, Smad1 and STAT3 (each 1.3 × 10 12 GC/ml). All vectors, except STAT3, are dual promoter vectors co-expressing fGFP. The total titre of fGFP-expressing vectors in this group is therefore 4.0 × 10 12 GC/ml. The ATF3 group and the fGFP group received DRG injections with dual vectors containing ATF3 and fGFP (4.0 × 10 12 GC/ml) or fGFP only (4.0 × 10 12 GC/ml), respectively.
At the 10-day time point, we included a non-injected control group (n = 6) and for the 8-week time point, which was used for functional testing, a sham control group was added (n = 9) in which the dorsal root were exposed but not transected. Experimental groups and group sizes are summarized in Table 1 .
Four weeks later, animals were anaesthetized with isoflurane and the left L3-L6 dorsal roots were exposed at L3 level. These dorsal roots were transected at the point midway between the levels of the L2 and L3 DRG, and the L4 and L5 roots were immediately re-ligated using one 10-O suture per root. The muscles overlying the spinal cord were loosely sutured together and the wound was closed.
Dorsal column injury
Treatment groups were as above: combination (n = 6), ATF3 (n = 5) and fGFP only (n = 5). Four weeks after viral vector injection in the left L4/L5 DRG, a laminectomy was performed after which a C4 bilateral dorsal column lesion was made as follows: a 30-gauge needle was inserted 1 mm either side of the midline to 1.6 mm depth. The resulting holes were then enlarged by inserting a 27-gauge needle to the same depth. Finally, the tips of a pair of microscissors were inserted in the same holes to the same depth and then closed. Animals were allowed to recover at 37°C and received postoperative analgesia (Temgesic; ScheringPlough). Survival time after injury was 4 weeks.
Three days before perfusion, animals in the 8-week time point after dorsal root injury and in the dorsal column injury group received 3 µl of 1% cholera toxin B (CTB) (103B, List Laboratories, Inc., Campbell, CA) into the sciatic nerve to transganglionically label dorsal root and dorsal column axons. Animals were injected with a lethal dose of pentobarbital and transcardially perfused with 0.9% saline followed by 4% paraformaldehyde in 0.1 mol/l phosphate buffer pH 7.4. Tissue was post-fixed for 3-4 h, transferred to 30% sucrose in phosphate-buffered saline and frozen in Tissue-Tek OCT (4583; Sakura Finetek Holland, Zoeterwoude, the Netherlands) the following day.
Immunohistochemical procedures
Rabbit polyclonal anti-ATF3 (1:400; SC-188, Santa Cruz), rabbit polyclonal anti-c-Jun (1:200; SC-1694, Santa Cruz), rabbit polyclonal anti-STAT3 (1:400; SC-482; Santa Cruz) or rabbit monoclonal anti-Smad1 (1:1000; clone EP565Y, Millipore) primary antibodies were used to visualize ATF3, c-Jun, STAT3 or Smad1, respectively, in every twelfth section of the DRG, cut at 20 µm thick. Sections were co-stained for GFP and βIII-tubulin using chicken anti-GFP (1:1000; AB16901; Millipore) and mouse anti-βIII-tubulin (1:500; clone TuJ1; Covance), followed by donkey anti-rabbit-Alexa594 (1:600; Jackson Immunoresearch), biotinylated goat anti-chicken (1:300; Vector Labs) and donkey antimouse DyLight649 (1:600; Jackson Immunoresearch), and finally streptavidin-Alexa488 (1:400; Jackson Immunoresearch).
In the dorsal root injury experiments, dorsal roots were cut into segments based on the location of the surgical suture at the lesion site as shown schematically in Figure 1 . Longitudinal sections of the lesion site, from 2 mm caudal to 3 mm rostral, were cut at 20 μm thick and placed onto Superfrost Plus slides (Menzel-Gläser). Segments of 1 mm were taken from 2 to 3 mm caudal, 3 to 4 mm rostral and 7 to 8 mm rostral and transverse 20-μm sections taken. For detection of fGFP, every sixth section of the dorsal root lesion sites and every second section of lumbar spinal cord were stained with rabbit anti-GFP (1:15 000; ab290; Abcam), followed by biotinylated horse antirabbit (1:300; Vector Labs), ABC reagent (1:200; Vector Labs), then washed in TBS containing 0.05% Tween 20 (P137-9; Sigma-Aldrich) and incubated in biotinyl tyramide reagent (1:400; NEL700A001KT; PerkinElmer) in TBS containing 0.001% H 2 O 2 , followed by streptavidin-Cy3 (1:400; Jackson Immunoresearch). Dorsal root and lumbar spinal cord sections were coimmunostained with mouse anti-neurofilament (1:500; 2H3; Dev. Stud. Hybridoma Bank, Univ. of Iowa) and mouse anti-GFAP (1:4000; G3893; Sigma), respectively, followed by donkey anti-mouse-Cy3 (1:600; Jackson Immunoresearch).
For the 8-week dorsal root lesions and the dorsal column experiment, spinal cord sections were stained with goat anti-CTB (1:80.000; 703, List Laboratories, Inc.), followed by biotinylated horse anti-goat (1:300; Vector Labs), ABC reagent (1:200; Vector Labs), then washed in TBS containing 0.05% Tween 20 (P137-9; Sigma-Aldrich) and incubated in biotinyl tyramide reagent (1:400; NEL700A001KT; PerkinElmer) in TBS containing 0.001% H 2 O 2 , followed by streptavidin-Cy3 (1:400; Jackson Immunoresearch). The sections were then blocked with Avidin/Biotin solution and co-immunostained with rabbit anti-GFP (1:15.000; ab290; Abcam) and mouse anti-GFAP (1:4000; G3893; Sigma), followed by horse anti-rabbit biotin (1:300; Vector Labs) and donkey anti-mouse Alexa647 (1:600; Jackson Immunoresearch). The sections were washed again in TBS containing 0.05% Tween 20 (P137-9; Sigma-Aldrich) and incubated in biotinyl tyramide reagent (1:400; NEL700A001KT; PerkinElmer) in TBS containing 0.001% H 2 O 2 , washed and finally incubated with streptavidinAlexa488 (1:400; Jackson Immunoresearch).
Histological analysis
Image analysis and quantification of DRG based on nuclear fluorescence intensity after immunostaining for a TF and GFP were performed in ImagePro Plus (Media Cybernetics) as previously described (31) . Longitudinal sections of the lesion site in dorsal roots were stained for GFP and neurofilament as described earlier.
Using ImagePro Plus software, a grid with counting lines at fixed intervals was laid over the photomicrographs by a blinded experimenter and GFP-or neurofilament-positive axons that crossed each grid line were counted. Regenerated axon counts distal to the lesion were expressed as percentages of the proximal axon counts. Transverse sections of the dorsal root were stained for GFP and neurofilament as described earlier. With an algorithm in ImagePro Plus software, axons in the red channel were identified based on roundness and size. For classification as a neurofilament-positive axon, a threshold of 2× the background level was chosen. For quantification of GFP-positive axons, a counting grid was laid over the photomicrographs and GFP-positive axons were manually counted by a blinded experimenter at 400% zoom. Regenerated axon counts distal to the lesion were expressed as percentages of the proximal axon counts.
The DREZ was visualized in sections of lumbar spinal cord by staining for GFAP. This structure has a complex shape with finger-like projections of peripheral and central nervous tissue intermingled. We quantified axons that had reached the DREZ as follows. Two lines were drawn to demarcate the peripheral and central borders of the DREZ. The former was placed at the furthest continuous extent into the dorsal root of GFAPpositive astrocytes and the latter at the furthest continuous extent towards the spinal cord of GFAP-negative Schwann cells. A third line for measurement of the crossing fibres was placed equidistant between them. GFP-labelled axons crossing the middle line were counted by a blinded experimenter. For the 8-week time point, GFP-and CTB-labelled axons in the DREZ were counted separately and axon counts in the DREZ were expressed as percentages of the proximal axon counts in dorsal roots. Some sections of the DREZ contained GFPpositive astrocytes. These astrocytes had likely been transduced owing to virus that travelled along the dorsal root. Animals that showed GFP-positive astrocytes were excluded from the analysis.
In images of spinal cord sections with a dorsal column injury, the lesion border was visualized by GFAP staining. We identified the most rostral axons positive for both GFP and CTB (both within and around the lesion) and measured the distance along the rostro-caudal axis relative to the proximal lesion border. To measure the extent of axonal growth into the lesion sites or axonal dieback, a counting grid with 250 µm spacing aligned with the lesion border was laid over the images to assess the number of double labelled axons at fixed distances proximal to, distal to, and at the lesion. The number of axons at each distance was normalized to the count at 750 µm caudal to the lesion border.
Functional tests
Recovery of sensory function in animals that received a dorsal root injury was tested weekly for 8 weeks by blinded experimenters using the Hargreaves plantar test (32) and the foot-flick test (33) . Animals were tested for 2 weeks prior to lesion to habituate them to the tests. The Hargreaves plantar test measures the withdrawal time of a paw after a noxious heat stimulus. Animals were unrestrained and placed in a box on top of a glass plate. An infra-red source is applied to the hind paw until withdrawal, and the time to withdrawal automatically recorded. The heat source intensity was adjusted so that withdrawal time was ∼10 s for uninjured animals. The stimulus was applied for a maximum of 20 s. Three measurements were taken for each animal. In the foot-flick test, animals were restrained and an increasing electrical stimulus applied to the left hind paw from 0.1 to 0.5 mA until a withdrawal reflex occurred. Autotomy scores were assessed weekly for each animal, which ranged from 1 to 5 with increasing severity (1-one toe partially affected; 2-one toe fully affected; 3-multiple toes affected; 4 -foot pad affected; 5-complete paw affected). Animals with severe autotomy were euthanized.
Results
We first investigated the feasibility of the co-delivery of transgenes by co-injection of multiple AAV vectors in the DRG. Equal titres of AAV vectors expressing GFP and mCherry were injected into adult rat L4 and L5 DRG and co-expression rates were quantified. A section of transduced DRG is shown in Figure 2 , where co-expression of GFP and mCherry can be clearly seen ( Fig. 2A) . mCherry only (Fig. 2B ), GFP only (Fig. 2C ) and βIII-tubulin only (Fig. 2D) are also shown. The expression rates and co-transduction rates are shown in Figure 2E . The co-transduction rate among all transduced neurons was on average 68%.
Overexpression of ATF3, Smad1, c-Jun and STAT3 in DRG
Following injection of AAV vectors expressing TFs and fGFP in the DRG and dorsal root injury, double-labelling immunofluorescence was performed for each TF and GFP in the injected DRG. Immunohistochemistry for the four TFs revealed strong protein expression of ATF3 in the ATF3-treated group and of all four factors in the combination group (Fig. 3A) . Expression levels of ATF3, c-Jun, STAT3, Smad1 and fGFP were quantified and the number of fGFP-positive cells co-expressing each TF determined. At the 10-day time point, for each of the four individual TFs, expression was seen in the majority (65-75%) of the GFP-positive neurons in the TF combination group, compared with 15-30% in the fGFP group (Fig. 3B) . In both the ATF3 and the combination group, the rate of ATF3 expression in GFP-positive cells was significantly more than that in the fGFP group (ANOVA, overall P-value = 6 × 10
, with Dunnett's post hoc test: combination versus fGFP P = 4 × 10 −5 ; ATF3 versus fGFP P = 0.002). In the combination group, expression rates in GFP-positive neurons were also higher for c-Jun, STAT3 and Smad1 (respective P-values 0.001, 0.04 and 1 × 10 −9 , unpaired t-test). The expected rates of co-expression of one, two, three or four TFs in GFP-positive cells, calculated from the expression rates of the four TFs, are shown in Table 2 . At the 20-day time point, expression rates of the TFs in GFPpositive neurons in the combination injected group were similar to the rates at 10 days, albeit slightly lower (55-60%), but c-Jun and ATF3 expression were unexpectedly increased in the fGFP group to similar levels. Rates of ATF3 expression in GFP-positive neurons were significantly higher in injected DRG of the ATF3 group (75%) but not the TF-combination group (58%) compared with the fGFP group at 39% (one-way ANOVA, overall P-value = 0.004, with Dunnett's post hoc test: ATF3 versus fGFP P = 0.002; combination versus fGFP n.s.) (Fig. 3B) . Expression rates in GFPexpressing cells of STAT3 (P = 0.008, unpaired t-test) and Smad1 (P = 7 × 10 −4 , unpaired t-test) in the TF combination group were again significantly greater than those in the fGFP group.
Transduction efficiency
To determine transduction rates, we measured the percentage of GFP-positive fibres in the dorsal root and quantified the number of axons positive for GFP as a percentage of neurofilament-positive fibres in transverse sections of the proximal part of the L4 and L5 dorsal roots ( Fig. 4A and B) . Transduction efficiencies ranged between 23 and 35% and did not differ significantly between groups (one-way ANOVA) (Fig. 4C) .
Regeneration in the dorsal root
Lesion site Following dorsal root lesion, regenerating axons were quantified at 10 and 20 days postlesion in longitudinal sections of the lesion sites, as shown in Figure 5A and schematically in Figure 1 . As shown in Figure 6A , at 10 days after transection, axon regeneration beyond the lesion site was significantly greater overall in both the ATF3 group and TF combination group compared with the fGFP group (Linear Mixed Model, overall P-value P = 0.01, with Tukey post hoc test: ATF3 versus fGFP P = 0.02; combination versus fGFP P = 0.03; ATF3 versus combination n.s.). No difference was seen between the ATF3 group and the combination group. At 20 days postinjury, there were no significant differences observed between groups (Fig. 6A) .
To determine whether viral vector injection in the DRG affected dorsal root regeneration by itself, dorsal root injury was also performed in a group of animals that did not receive a viral vector injection, and regenerating neurofilament-positive axons were quantified in this group and in the fGFP group at 10 days after dorsal root transection and repair. We observed no differences in neurofilament-positive axons between these two groups, indicating that the vector injection itself has no effect on axon regeneration (n.s. by Linear Mixed Model) (Fig. 6B) .
Distal dorsal root
Regeneration was also examined in transverse sections of the dorsal roots, which were taken at 3.5 mm and 7.5 mm distal and 2.5 mm proximal to the lesion and immunostained for GFP and neurofilament. As shown in Figure 6C , at the 10-day time point, the mean percentages of GFP-positive fibres reaching the distal nerve segments appeared higher in both groups that received TFs compared with the fGFP control group; this was only significant in the overall test at 7.5 mm (Weighted Least Squares ANOVA; at 3.5 mm distal n.s.; at 7.5 mm P = 0.02; Tukey post hoc tests were n.s.). At 20 days and 8 weeks postinjury, there were no significant differences between groups (Fig. 6C ).
Dorsal root entry zone
In GFAP immunostained sections of the DREZ at the L4/L5 level, a clear astrocytic border was visible ( Fig. 5B and C) . Furthermore, GFP-positive axons were seen to reach and enter the DREZ in all groups ( Fig. 5B and E) . As shown in Figure 5C , a quantification grid was laid over the DREZ based on the inner and outer border determined by GFAP labelling in order to quantify the number of GFP-positive axons reaching the DREZ. In general, most axons were found on the peripheral side of the astrocytic border. The number of axons crossing the central line was normalized to the total number of GFP-positive axons counted in the proximal dorsal root. In the animals of the 8-week time point, the number of CTBpositive axons was also counted (Fig. 5D) . The number of CTBpositive axons was normalized to the total number of 2H3 positive axons found in transverse sections of the proximal dorsal root. At 10 days after dorsal root transection and repair, there were no significant differences (by one-way ANOVA) in the number of GFP-positive axons per section entering the DREZ between the groups (Fig. 7A) . At 20 days, the number of GFP-positive fibres was significantly increased in the ATF3 and the TF combination groups compared with the fGFP control group (Fig. 7A ) (one-way ANOVA, overall test P = 0.01, with Tukey post hoc tests: ATF3 versus fGFP, P = 0.04; combination versus fGFP, P = 0.02; combination versus ATF3 n.s.). However, at 8 weeks, there were no significant differences observed in either GFP-positive (Fig. 7A) or CTB-positive ( Fig. 7B) axon counts. A small number of axons were found to cross the DREZ in animals of all three groups, entering the GFAP-rich area beyond and sometimes even the dorsal horn grey matter. However, quantification of the number of axons entering the dorsal horn and of the degree of penetration of the furthest axon did not reveal significant differences between groups (Fig. 7C and D) .
Functional testing
Recovery of sensory function was examined weekly during 8 weeks following dorsal root injury, using two tests of nociception, the foot-flick test (an electrical nociceptive stimulus) and the Hargreaves plantar test (a thermal nociceptive stimulus). Directly after injury, sensitivity to nociceptive stimulation was severely reduced in all groups that received an injury, whereas sham animals remained at baseline levels. There were no differences between viral-vector-treated groups in their responses to either stimulus ( Fig. 8A and B) .
Autotomy
Autotomy was observed in some animals treated with TFs (Fig. 8C) , and this was significantly more prevalent in the ATF3 group, compared with the fGFP group, whereas a non-significant increase was seen for animals in the TF combination-treated group (Kruskall-Wallis test for three independent groups, expression rates of all four TFs were similar to those at 10 days, and for STAT3 and Smad1, expression was significantly higher than that in the fGFP controls. However, high levels of endogenous expression of ATF3 and c-Jun were observed in the fGFP-only group, and ATF3 expression was higher only in the ATF3-only group. *P < 0.05, **P < 0.01, ***P < 0.001. Error bars are SEM. 
Dorsal column injury
We also assessed the effects of overexpression of ATF3 and the combination of TFs on regeneration of ascending dorsal column axons after lesion. Transganglionic tracing of injured dorsal column axons was performed using CTB 4 weeks after injury. The lesion site was visualized with GFAP immunolabelling, and the ascending fibres were immunolabelled with GFP and CTB ( Fig. 5F-H) . We observed no differences in the maximum penetration distance of regenerating dorsal column axons (Fig. 9A) . Quantification of double-labelled GFP-and CTB-positive fibres showed that there were also no differences in growth into the lesion or in die-back of injured axons caudal to the lesion (by Linear Mixed Model) (Fig. 9B ).
Discussion
In this study, we aimed to enhance the regenerative response of injured DRG neurons after injury of their central axon branches by delivery of regeneration-associated TFs, in the absence of a conditioning lesion. We injected AAV5 dual promoter vectors expressing fGFP alone, fGFP and ATF3 or a mixture of vectors expressing fGFP with ATF3, c-Jun, STAT3 and Smad1 into rat DRG. Regenerative growth was assessed after dorsal root or dorsal column injury. We hypothesized that combined overexpression of multiple regeneration-associated TFs would be more effective at enhancing axon growth than a single factor, namely ATF3.
The speed of central axon regeneration was enhanced by delivery of both ATF3 alone and by the combination of TFs. At 10 days after dorsal root transection and repair, this was visible immediately distal to the transection site. At 20 days, effects were seen more distally, in the number of axons reaching the DREZ. Finally, 8 weeks after injury, there were no differences between groups. These results demonstrate that overexpression of ATF3 and combinatorial overexpression of ATF3, c-Jun, STAT3 and Smad1 leads to an increase in speed of regeneration of injured dorsal root axons. Surprisingly, however, delivery of multiple regeneration-associated TFs was not more effective than expressing ATF3 alone.
TF-expressing axons appear to regenerate faster, and so more of them reach distances up to 7.5 mm by 10 days. At 20 days, no difference can be seen in the proximal measurements (up to 7.5 mm) most likely because most axons in the fGFP-only group have also regenerated to 7.5 mm, and no additional axons cross the lesion site. The percentages of axons that have grown to 3.5 and 7.5 mm were stable between 20 days and 8 weeks, as expected, whereas the number of axons reaching the DREZ at 8 weeks appears to have declined compared with 20 days, which indicates that some partial retraction may occur in this period. In longitudinal sections of the lesion site, the axon counts appear to be reduced at the point of anastamosis and then increase in the more distal parts, particularly at 20 days after injury. This is likely because at the point of injury the tissue becomes somewhat disorganised such that axons are not aligned with the axis of the nerve (visible in Fig. 5A ), reducing the counts of axons that cross the measurement lines.
As mentioned, ATF3, c-Jun, STAT3 and Smad1 have individually been shown to contribute to regenerative axon growth of injured DRG neurons. Improved regeneration of the peripheral branch of DRG neurons by ATF3 was reported in transgenic mice overexpressing ATF3 (11) . ATF3 expression was insufficient to promote regeneration of injured dorsal column axons in the transgenic mouse model, consistent with our findings. However, we show here for the first time that ATF3 overexpression does also enhance the speed of regeneration of the central branch of DRG neurons, when injured in the more favourable environment of the dorsal root. Both Smad1 and STAT3 individually have previously been shown to enhance axon sprouting of injured ascending sensory axons (9, 13, 14) . Overexpression of STAT3 in DRG neurons resulted in a rapid but short-lived increase in axonal sprouting of ascending dorsal column axons (14) . We have looked at later time points after injury, by which time such short-lived effects on axon growth would no longer be visible. Activation of Smad1 by AAV-mediated BMP4 overexpression was shown to increase regeneration of injured ascending sensory axons 4 weeks after dorsal column transection (13) . Here, we have used a constitutively active form of Smad1 (Smad1-EVE), which is active independent of BMP signalling (30) . However, we did not observe increased axon growth of injured dorsal column axons by overexpression of the combination of regeneration-associated TFs, which included this constitutively active form of Smad1. Delivery of BMP4 leads to Smad1 activation in transduced DRG neurons but may also activate other pathways.
Expression of the combination of four TFs had similar effects to expression of ATF3 only. We chose an experimental set-up such that the total titre of fGFP-expressing virus was matched between the fGFP only, ATF3, and combination groups. In this way, any improvement in regeneration by the combination over ATF3 would be clearly due to synergistic effects. The alternative would be delivery of a four-fold higher titre in the combination group, upon which any positive effect may simply be due to having four times as much expression of any RAG TFs. We did not find synergistic effects upon delivery of multiple regeneration-associated TFs compared with overexpression of a single TF, for which there may be several explanations. Co-expression of each TF with GFP was in the range of 60-75% at 10 days postlesion, and multiplying the four percentages would suggest that ∼24% of neurons with GFP are expected to express all four TFs. This may be too low for subtle effects to be apparent in the dorsal root injury model, where relatively slow regeneration occurs anyway without treatment, but strong positive effects should be observable at least in the dorsal column injury model where the baseline regeneration is minimal without a conditioning lesion. The efficient co-expression of more than two transgenes using AAV vectors remains difficult. One alternative is the 2A-peptide system, which enables co-delivery of multiple proteins by co-translational peptide cleavage using a single transcript (34) , but this would be precluded in experiments such as those carried out here by the size limit of 5 kb on AAV viral vectors.
A possible confounding factor was that we observed a delayed upregulation of endogenous ATF3 and c-Jun in the fGFP-only control group at 20 days after dorsal root injury. This was unexpected as previous studies of gene expression after dorsal root injury indicated a weak and short-lived upregulation of these factors, which declines by 1 week after injury (35) (36) (37) . This endogenous expression in response to dorsal root injury may have diminished potential differences in axonal growth between the fGFP group and the TF combination group. Also, while we have overexpressed activated forms of STAT3 and Smad1, wild-type c-Jun was used in this study. As mentioned, c-Jun can be activated by phosphorylation, which occurs after axotomy (38) (39) (40) and in vitro studies suggest that phosphorylation of c-Jun by Jun N-terminal kinases (JNKs) might be important for neurite outgrowth of DRG neurons (40) . The use of a pseudophosphorylated form of c-Jun might have resulted in greater synergistic effects of simultaneous overexpression of ATF3, c-Jun, Smad1 and STAT3. This seems unlikely, however, since knock-in replacement of Jun with a mutant not phosphorylatable by JNKs had essentially no effect on axon regeneration in vivo (41) .
With the approach taken here, it is also true that AAV vectors drive expression of the TFs at an arbitrary level, whereas the relative amounts of each TF may be important. A specific temporal sequence of expression may also be necessary to achieve RAG activation. In both cases, more subtle control over expression levels will be needed, for example with the use of regulatable promoters.
Our results suggest that the combination of ATF3, c-Jun, STAT3 and Smad1 is not the key regulatory complex of the RAG programme and does not activate the full RAG programme, which, as demonstrated by the conditioning lesion paradigm, can drive regeneration across the DREZ and into spinal cord lesions (4, 5) . Many other TFs are associated with successful axon regeneration, for example CREB, SOX11, NFIL3, C/EBPbeta, C/EBPdelta and several KLF family members (37, (42) (43) (44) (45) . Regulation of the RAG programme may also involve epigenetic mechanisms (46) . The identification of the key TFs capable of robustly promoting regeneration will require a better understanding of the full regulatory network controlling RAGs.
Although in general the specific targets of RAG TFs during axon regeneration are not well known, some RAGs are known to be potential target genes of ATF3, c-Jun, STAT3 and Smad1. For example, ATF3 overexpression drives expression of Hsp27 and SPRR1A (11, 47) , c-Jun may induce CD44, galanin and α7β1-integrin (7), STAT3 regulates NPY and possibly Reg2 (48, 49) and Smad1 may regulate GAP43 (13) . Overexpression of ATF3, c-Jun, STAT3 and Smad1 may induce partial activation of the RAG programme, but not enough to drive a very strong regenerative response. It is possible that these TFs support more general processes that occur in an injured neuron that do not directly influence axon regeneration, perhaps by boosting overall gene expression or increasing cell metabolism in response to stressful stimuli. Such a function may be redundantly carried out by several or all of the TFs overexpressed here, consistent with the lack of additive effects that we saw.
An unexpected finding was that animals that received ATF3 only displayed an increased tendency towards autotomy accompanied by inflammation in the left hind paw. This is unlikely to be an effect mediated directly via the central afferents as all sensory input from the transduced neurons was removed. It may indicate an increased tendency towards production of certain inflammatory stimuli as a result of ATF3 expression, acting in combination with the loss of sensory input. Such a finding indicates that TF delivery in neurons may not be without unwanted side-effects.
Several other studies have attained regeneration of dorsal root axons across the DREZ into the spinal cord by means of manipulating neuronal gene expression (50) (51) (52) . These studies used dorsal root crush injuries rather than transection, following which regeneration is more efficient to begin with. We used a transection lesion to ensure fibre sparing was not possible. However, these studies show that regrowth of injured dorsal root axons into the spinal cord is possible using neuron-intrinsic approaches.
In conclusion, this study shows for the first time that ATF3 overexpression enhances axon regeneration of the central branch of DRG neurons. Although no synergistic effects were found after simultaneous overexpression of ATF3, c-Jun, STAT3 and Smad1 compared with ATF3 alone, we demonstrate that regeneration of injured dorsal root axons can be enhanced by expression of a regeneration-associated TF in the absence of a conditioning lesion.
